Filing Details
- Accession Number:
- 0001493152-24-047998
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-27 16:15:24
- Reporting Period:
- 2024-11-19
- Accepted Time:
- 2024-11-27 16:15:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1904286 | Mira Pharmaceuticals Inc. | MIRA | Pharmaceutical Preparations (2834) | 853354547 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1986112 | Erez Aminov | C/O Mira Pharmaceuticals, Inc. 1200 Brickell Ave. Suite 1950 #1183 Miami FL 33131 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-11-19 | 55,410 | $1.39 | 1,105,790 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-11-20 | 44,590 | $1.27 | 1,061,200 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the Reporting Person on 8/20/2024.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions.